Effects of micronized progesterone added to non-oral estradiol on lipids and cardiovascular risk factors in early postmenopause: a clinical trial

<p>Abstract</p> <p>Background</p> <p>Much attention has been drawn to the deleterious effects of adding progestins to estrogen as hormone therapy (HT) in postmenopausal women. Some widely prescribed progestins have been shown to partially oppose the beneficial effects o...

Full description

Bibliographic Details
Main Authors: Casanova Gislaine, Spritzer Poli
Format: Article
Language:English
Published: BMC 2012-10-01
Series:Lipids in Health and Disease
Subjects:
Online Access:http://www.lipidworld.com/content/11/1/133